Advanced Renal Cell Cancer and Low-Dose Palliative Radiation Treatment: A Case of a Substantial and Sustained Treatment Response

Advanced Renal Cell Cancer and Low-Dose Palliative Radiation Treatment: A Case of a Substantial and Sustained Treatment Response

Clear cell carcinoma is the most common form of renal cell carcinoma (RCC). Metastatic RCC is poorly responsive to treatment and has a bleak prognosis. Newer systemic agents have improved outcomes. Furthermore, their interaction with radiation treatment (RT) may provide further therapeutic options....

Full description

Bibliographic Details
Main Authors: Kirsten van Gysen, Andrew Kneebone, Thomas Eade, Alexander Guminski, George Hruby
Format: Article
Language:English
Published: Karger Publishers 2018-11-01
Series:Case Reports in Oncology
Subjects:
Immunotherapy
Radiation therapy
Renal cell carcinoma
Targeted therapy
Online Access:https://www.karger.com/Article/FullText/493913
Description
Summary:Clear cell carcinoma is the most common form of renal cell carcinoma (RCC). Metastatic RCC is poorly responsive to treatment and has a bleak prognosis. Newer systemic agents have improved outcomes. Furthermore, their interaction with radiation treatment (RT) may provide further therapeutic options. RCC is considered to be radioresistant, however we report the case of a patient with progression on targeted therapy and immunotherapy who achieved a substantial and sustained local, and possibly abscopal, response to low dose palliative radiation therapy.
ISSN:1662-6575

Similar Items